SCHEMBL8086038

SCHEMBL8086038

CCCCCCCCCCCCSC(CC)C(=O)NNC(CC)C(=O)Nc1cc(C)c(O)c(C)c1C

nearest known ligand 0.59

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
SOAT2 O75908 1/20 0.59
ACAT1 P24752 1/20 0.59
SOAT1 P35610 1/20 0.59
PLK1 P53350 3/20 0.32
ESR1 P03372 1/20 0.31
MET P08581 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8049436 0.90 SOAT2 (0.68) SOAT2ACAT1SOAT1PLK1ESR1
SCHEMBL8079964 0.84 SOAT2 (0.56) SOAT2ACAT1SOAT1PLK1ESR1
SCHEMBL8042246 0.82 SOAT2 (0.67) SOAT2ACAT1SOAT1PLK1ESR1
SCHEMBL8416104 0.82 SOAT2 (0.67) SOAT2ACAT1SOAT1PLK1ESR1
SCHEMBL8043445 0.80 SOAT2 (0.69) SOAT2ACAT1SOAT1PLK1ESR1
SCHEMBL8049344 0.78 SOAT2 (0.67) SOAT2ACAT1SOAT1PLK1ESR1
SCHEMBL8043291 0.76 SOAT2 (0.59) SOAT2ACAT1SOAT1PLK1ESR1
SCHEMBL8071717 0.76 SOAT2 (0.52) SOAT2ACAT1SOAT1PLK1MET
SCHEMBL24482943 0.74 SOAT2 (0.62) SOAT2ACAT1SOAT1PLK1ESR1
Eflucimibe SCHEMBL29427708 0.74 SOAT2 (1.00) SOAT2ACAT1SOAT1PLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0871611-B1 NEW DERIVATIVES OF GLYCYLANILIDES, PREPARATION AND THERAPEUTICAL APPLICATION PF MEDICAMENT (FR) 2000-09-13 EP claimed
US-5760087-A ANTICHOLESTEROL AGENTS PIERRE FABRE MEDICAMENT (FR) 1998-06-02 US claimed
EP-0871611-B1 NEW DERIVATIVES OF GLYCYLANILIDES, PREPARATION AND THERAPEUTICAL APPLICATION PF MEDICAMENT (FR) 2000-09-13 EP disclosed
US-5760087-A ANTICHOLESTEROL AGENTS PIERRE FABRE MEDICAMENT (FR) 1998-06-02 US disclosed